Elbaridi, Nidal
Elbaridi, Nidal was paid $929K by Medicaid between Feb 2018 and Oct 2024, across 15 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 70% of everything it billed.
CHICAGO, IL 60616
Next to other Anesthesiology Physician providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 104 | $2K | |
| 2019 | 382 | $19K | |
| 2020 | 2,481 | $59K | |
| 2021 | 8,795 | $361K | |
| 2022 | 12,645 | $453K | |
| 2023 | 1,013 | $34K | |
| 2024incomplete | 98 | $547.60 |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 70% | 8,456 | 4,587 | $650K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 12% | 4,544 | 2,766 | $112K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 12% | 9,099 | 4,693 | $109K |
| 99201 | 1.5% | 514 | 386 | $14K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.4% | 1,085 | 770 | $13K |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | 1.4% | 31 | 18 | $13K |
| 99000 | <1% | 441 | 346 | $6K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 160 | 131 | $6K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 777 | 645 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 51 | 37 | $1K |
| 99152 | <1% | 48 | 25 | $14.98 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 130 | 75 | $9.84 |
3 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.